Company / Free Cash Flow per Share
Tandem Diabetes Care Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.45
FY2025
5-year range
-$0.91 / $0.36
FY2021-FY2025
Trend
-687.7%
vs FY2024
Sector context
#130 of 148
Health Care
What the data says
Free Cash Flow per Share changed -688% YoY in FY2025, a notable deviation from the 9-year average annual change of -331%.
Based on SEC 10-K filings.
-0.45 in FY2025.
Improved from $-0.91 to $-0.45 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 148This company -$0.45 Sector average $5.05
▼
-108.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 687.7% year-over-year.
- Ranks #130 out of 148 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.45 | -687.7% |
| FY2024 | $0.08 | +108.4% |
| FY2023 | -$0.91 | -2017.4% |
| FY2022 | -$0.04 | -112.0% |
| FY2021 | $0.36 | +288.5% |
| FY2020 | -$0.19 | +84.8% |
| FY2019 | -$1.25 | +82.0% |
| FY2018 | -$6.93 | +66.6% |
| FY2017 | -$20.75 | -795.5% |
| FY2016 | -$2.32 | +15.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026